Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus.
Rheumatology (Oxford)
; 62(7): 2601-2610, 2023 07 05.
Article
in En
| MEDLINE
| ID: mdl-36370065
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lupus Erythematosus, Systemic
/
Antibodies
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Rheumatology (Oxford)
Journal subject:
REUMATOLOGIA
Year:
2023
Type:
Article
Affiliation country:
United kingdom